Effect of short hairpin RNA-induced CXCR4 silence on ovarian cancer cell

Biomedicine and Pharmacotherapy

Volumn 66, Issue 7, 2012, Pages 549-553

  Chen, Hai Ying ^a   Wang, Jing Mao ^b   Wang, Hong Ying ^b   Zhang, Ying Xin ^a   Liu, Wei ^a   Pan, Li ^a   Wang, Wei Hua ^a   Chen, Shuang Feng ^a   Jin, Wei Guo ^b   Wang, Lexin ^c  

^a LIAOCHENG PEOPLE'S HOSPITAL   (China)

^b Luanxian People's Hospital   (China)

^c CHARLES STURT UNIVERSITY   (Australia)

Author keywords

CXC chemokine receptor 4; Ovarian cancer; Small interfering RNA; SW626

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CHEMOKINE RECEPTOR CXCR4; MATRIGEL; PLASMID VECTOR; SHORT HAIRPIN RNA;

ARTICLE; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULARLY TARGETED THERAPY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENE SILENCING; GENETIC VECTORS; HUMANS; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; PLASMIDS; RECEPTORS, CXCR4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING;

EID: 84867334837     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2012.04.007     Document Type: Article

References (21)

1. Barbieri F., Bajetto A., Florio T. Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target. J Oncol 2010, 2010:426-956.
2. Ziebarth A.J., Landen C.N., Alvarez R.D. Molecular/Genetic therapies in ovarian cancer: future opportunities and challenges. Clin Obstet Gynecol 2012, 55(1):156-172.
3. Wang H., Linghu H., Wang J., Che Y.L., Xiang T.X., Tang W.X., et al. The role of Crk/Dock180/Rac1 pathway in the malignant behavior of human ovarian cancer cell SKOV3. Tumour Biol 2010, 31(1):59-67.
4. Sekiya R., Kajiyama H., Sakai K., Umezu T., Mizuno M., Shibata K., et al. Expression of CXCR4 indicates poor prognosis in patients with clear cell carcinoma of the ovary. Hum Pathol 2012, 43(6):904-910.
5. Kwong J., Kulbe H., Wong D., Chakravarty P., Balkwill F. An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells. Mol Cancer Ther 2009, 8(7):1893-1905.
6. Busillo J.M., Benovic J.L. Regulation of CXCR4 signaling. Biochim Biophys Acta 2007, 1768(4):952-963.
7. Kochetkova M., Kumar S., McColl S.R. Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells. Cell Death Differ 2009, 16(5):664-673.
8. Chetram M.A., Odero-Marah V., Hinton C.V. Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells. Mol Cancer Res 2011, 9(1):90-102.
9. Cuccato G., Polynikis A., Siciliano V., Graziano M., di Bernardo M., di Bernardo D. Modeling RNA interference in mammalian cells. BMC Syst Biol 2011, 5:19.
10. Abedini F., Ismail M., Hosseinkhani H., Ibrahim T.A., Omar A.R., Chong P.P., et al. Effects of CXCR4-siRNA/dextran-spermine nanoparticles on CXCR4 expression and serum LDH levels in a mouse model of colorectal cancer metastasis to the liver. Cancer Manag Res 2011, 3:301-309.
11. Wang Y., Chen Y., Wang J., Chen J., Aggarwal B.B., Pang X., et al. Xanthohumol, a Prenylated Chalcone Derived from Hops, Suppresses Cancer Cell Invasion through Inhibiting the Expression of CXCR4 Chemokine Receptor. Curr Mol Med 2012, 12(2):153-162.
12. Sakai N., Yoshidome H., Shida T., Kimura F., Shimizu H., Ohtsuka M., et al. CXCR4/CXCL12 expression profile is associated with tumor microenvironment and clinical outcome of liver metastases of colorectal cancer. Clin Exp Metastasis 2012, 29(2):101-110.
13. Koizumi K., Kato S., Sakurai H., Hashimoto I., Yasumoto K., Saiki I. Therapeutics target of CXCR4 and its downstream in peritoneal carcinomatosis of gastric cancer. Front Biosci (Schol Ed) 2012, 4:269-276.
14. Griffin T.J., Gygi S.P., Ideker T., Rist B., Eng J., Hood L., et al. Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol Cell Proteomics 2002, 1(4):323-333.
15. Yu T., Wu Y., Huang Y., Yan C., Liu Y., Wang Z., et al. RNAi targeting CXCR4 inhibits tumor growth through inducing cell cycle arrest and apoptosis. Mol Ther 2012, 20(2):398-407.
16. Denis C.L., Drouin E.E. Meiotic instability of tandemly iterated plasmid sequences in the yeast chromosome. Curr Genet 1987, 12(6):399-403.
17. Torregrossa L., Giannini R., Borrelli N., Sensi E., Melillo R.M., Leocata P., et al. CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas. Mod Pathol 2012, 25(1):46-55.
18. Wang J., Cai J., Han F., Yang C., Tong Q., Cao T., et al. Silencing of CXCR4 blocks progression of ovarian cancer and depresses canonical Wnt signaling pathway. Int J Gynecol Cancer 2011, 21(6):981-987.
19. Porcile C., Bajetto A., Barbero S., Pirani P., Schettini G. CXCR4 activation induces epidermal growth factor receptor transactivation in an ovarian cancer cell line. Ann N Y Acad Sci 2004, 1030:162-169.
20. Hsu E.L., Chen N., Westbrook A., Wang F., Zhang R., Taylor R.T., et al. CXCR4 and CXCL12 down-regulation: a novel mechanism for the chemoprotection of 3,3'-diindolylmethane for breast and ovarian cancers. Cancer Lett 2008, 265(1):113-123.
21. Miyanishi N., Suzuki Y., Simizu S., Kuwabara Y., Banno K., Umezawa K. Involvement of autocrine CXCL12/CXCR4 system in the regulation of ovarian carcinoma cell invasion. Biochem Biophys Res Commun 2010, 403(1):154-159.